trending Market Intelligence /marketintelligence/en/news-insights/trending/5DnNDBHx-EAIkQ18dnix-A2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Bruker completes $300M loan, other measures under debt financing strategy

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Bruker completes $300M loan, other measures under debt financing strategy

Bruker Corp. completed a $300 million seven-year term loan in addition to a five-year revolving credit facility and private placement of senior notes under its debt financing strategy.

The Billerica, Mass.-based manufacturer of scientific instruments and diagnostic solutions can borrow up to $600 million under the revolving facility, which replaces the October 2015 $500 million credit facility that was terminated. Bruker also sold 1.01% senior notes for CHF297 million that are due Dec. 11, 2029.

Bruker plans to use the funds from the debt financing for general corporate purposes, including the repayment of outstanding borrowings. Additionally, the proceeds will support the company's corporate strategic objectives.

This financing will extend the debt maturities out to 2026 and 2029, according to the company's Dec. 12 press release.